Healthcare Professionals
-
TIF Publications
A TIF-proposed Haemoglobinopathy Patient Pathway During the COVID-19 Pandemic (2020)
A Patient Care Pathway recommending adjustments to be implemented in the admission of patients to haemoglobinopathy centers, units, or clinics during the COVID-19 pandemic.
Read More » -
TIF News
The changing epidemiology of the ageing thalassaemia populations: A new position statement by TIF
Therapeutic advances in β-thalassaemia have gradually led to a significant improvement in prognosis over the past few decades. As a result, patients living in areas where disease specific programmes offer…
Read More » -
News
Novartis To Donate Up To 130 Million Doses Of Hydroxychloroquine To Treat Covid-19
On Friday, 20 March, Novartis announced its commitment to donate up to 130 million doses of generic hydroxychloroquine to support the global COVID-19 pandemic response. Hydroxychloroquine and a related…
Read More » -
Renzo Galanello
-
News
Clinical trials Updates – July 2017
Last update: July 2017 Luspatercept A novel agent that increases haemoglobin by promoting erythropoiesis. More specifically it promotes the differentiation and maturation of late-stage erythrocyte precursors by acting as a…
Read More » -
TIF Publications
Guidelines for the Management of Non-Transfusion Dependent Thalassaemia (NTDT) (2nd Edition – 2017)
Ali T. Taher, MD PhD FRCP Khaled M. Musallam, MD PhD Maria Domenica Cappellini, MD FACP
Read More » -
TIF Publications
A Short Guide for the Management of Transfusion Dependent Thalassaemia (2017)
Prepared by: Farmakis, D. Angastiniotis, M. Eleftheriou, A.
Read More » -
Preceptorships
-
News
-
Member News
Approval of HSCT project for the cure of Thalassaemia patients by the Govt. of India
Coal India Ltd. under their CSR activity in coordination with the Ministry of Health and Family Welfare, Govt. of India has approved an HSCT project for the cure of thalassemia patients.…
Read More »